{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T00:16:01Z","timestamp":1793924161896,"version":"4.8.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,13]],"date-time":"2021-09-13T00:00:00Z","timestamp":1631491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,13]],"date-time":"2021-09-13T00:00:00Z","timestamp":1631491200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000049","name":"national institute on aging","doi-asserted-by":"publisher","award":["U24 AG072122"],"award-info":[{"award-number":["U24 AG072122"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"national institute on aging","doi-asserted-by":"publisher","award":["P01AG03991"],"award-info":[{"award-number":["P01AG03991"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"national institute on aging","doi-asserted-by":"publisher","award":["P01 AG026276"],"award-info":[{"award-number":["P01 AG026276"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"national institute on aging","doi-asserted-by":"publisher","award":["K01 AG 053474"],"award-info":[{"award-number":["K01 AG 053474"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"national institute on aging","doi-asserted-by":"publisher","award":["P30AG066444"],"award-info":[{"award-number":["P30AG066444"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Comprehensive testing of cognitive functioning is standard practice in studies of Alzheimer disease (AD). Short-form tests like the Montreal Cognitive Assessment (MoCA) use a \u201csampling\u201d of measures, administering key items in a shortened format to efficiently assess cognition while reducing time requirements, participant burden, and administrative costs. We compared the MoCA to a commonly used long-form cognitive battery in predicting AD symptom onset and sensitivity to AD neuroimaging biomarkers.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Survival, area under the receiver operating characteristic (ROC) curve (AUC), and multiple regression analyses compared the MoCA and long-form measures in predicting time to symptom onset in cognitively normal older adults (<jats:italic>n<\/jats:italic> = 6230) from the National Alzheimer\u2019s Coordinating Center (NACC) cohort who had, on average, 2.3 \u00b1 1.2 annual assessments. Multiple regression models in a separate sample (<jats:italic>n<\/jats:italic> = 416) from the Charles F. and Joanne Knight Alzheimer Disease Research Center (Knight ADRC) compared the sensitivity of the MoCA and long-form measures to neuroimaging biomarkers including amyloid PET, tau PET, and cortical thickness.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Hazard ratios suggested that both the MoCA and the long-form measures are similarly and modestly efficacious in predicting symptomatic conversion, although model comparison analyses indicated that the long-form measures slightly outperformed the MoCA (HRs &gt; 1.57). AUC analyses indicated no difference between the measures in predicting conversion (DeLong\u2019s test, <jats:italic>Z<\/jats:italic> = 1.48, <jats:italic>p<\/jats:italic> = 0.13). Sensitivity to AD neuroimaging biomarkers was similar for the two measures though there were only modest associations with tau PET (<jats:italic>r<\/jats:italic>s = \u2212\u20090.13, <jats:italic>p<\/jats:italic>s &lt; 0.02) and cortical thickness in cognitively normal participants (<jats:italic>r<\/jats:italic>s = 0.15\u20130.16, <jats:italic>p<\/jats:italic>s &lt; 0.007).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Both test formats showed weak associations with symptom onset, AUC analyses indicated low diagnostic accuracy, and biomarker correlations were modest in cognitively normal participants. Alternative assessment approaches are needed to improve how clinicians and researchers monitor cognitive changes and disease progression prior to symptom onset.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13195-021-00894-5","type":"journal-article","created":{"date-parts":[[2021,9,13]],"date-time":"2021-09-13T16:03:19Z","timestamp":1631548999000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Is comprehensiveness critical? Comparing short and long format cognitive assessments in preclinical Alzheimer disease"],"prefix":"10.1186","volume":"13","author":[{"given":"Jason","family":"Hassenstab","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Nicosia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"LaRose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Aschenbrenner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian A.","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tammie L. S.","family":"Benzinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengjie","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,13]]},"reference":[{"issue":"5","key":"894_CR1","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1017\/S1355617706060863","volume":"12","author":"EW Twamley","year":"2006","unstructured":"Twamley EW, Ropacki SA, Bondi MW. Neuropsychological and neuroimaging changes in preclinical Alzheimer\u2019s disease. J Int Neuropsychol Soc. 2006;12(5):707\u201335. https:\/\/doi.org\/10.1017\/S1355617706060863.","journal-title":"J Int Neuropsychol Soc"},{"issue":"10","key":"894_CR2","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S1474-4422(13)70194-7","volume":"12","author":"SJ Vos","year":"2013","unstructured":"Vos SJ, Xiong C, Visser PJ, Jasielec MS, Hassenstab J, Grant EA, et al. Preclinical Alzheimer\u2019s disease and its outcome: a longitudinal cohort study. Lancet Neurol. 2013;12(10):957\u201365. https:\/\/doi.org\/10.1016\/S1474-4422(13)70194-7.","journal-title":"Lancet Neurol."},{"issue":"1","key":"894_CR3","doi-asserted-by":"publisher","first-page":"231","DOI":"10.3233\/JAD-150128","volume":"47","author":"EC Edmonds","year":"2015","unstructured":"Edmonds EC, Delano-Wood L, Galasko DR, Salmon DP, Bondi MW. Subtle cognitive decline and biomarker staging in preclinical Alzheimer\u2019s disease. J Alzheimers Dis. 2015;47(1):231\u201342. https:\/\/doi.org\/10.3233\/JAD-150128.","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"894_CR4","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack Jr","year":"2018","unstructured":"Jack CR Jr, Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, et al. NIA-AA research framework: toward a biological definition of Alzheimer\u2019s disease. Alzheimers Dement. 2018;14(4):535\u201362. https:\/\/doi.org\/10.1016\/j.jalz.2018.02.018.","journal-title":"Alzheimers Dement"},{"issue":"3","key":"894_CR5","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1037\/0882-7974.21.3.545","volume":"21","author":"MJ Sliwinski","year":"2006","unstructured":"Sliwinski MJ, Smyth JM, Hofer SM, Stawski RS. Intraindividual coupling of daily stress and cognition. Psychol Aging. 2006;21(3):545\u201357. https:\/\/doi.org\/10.1037\/0882-7974.21.3.545.","journal-title":"Psychol Aging"},{"key":"894_CR6","doi-asserted-by":"publisher","first-page":"102812","DOI":"10.1016\/j.concog.2019.102812","volume":"75","author":"V Bambrah","year":"2019","unstructured":"Bambrah V, Hsu CF, Toplak ME, Eastwood JD. Anticipated, experienced, and remembered subjective effort and discomfort on sustained attention versus working memory tasks. Conscious Cogn. 2019;75:102812. https:\/\/doi.org\/10.1016\/j.concog.2019.102812.","journal-title":"Conscious Cogn"},{"issue":"17","key":"894_CR7","doi-asserted-by":"publisher","first-page":"7922","DOI":"10.1073\/pnas.0910662107","volume":"107","author":"JT McGuire","year":"2010","unstructured":"McGuire JT, Botvinick MM. Prefrontal cortex, cognitive control, and the registration of decision costs. Proc Natl Acad Sci. 2010;107(17):7922\u20136. https:\/\/doi.org\/10.1073\/pnas.0910662107.","journal-title":"Proc Natl Acad Sci"},{"issue":"7","key":"894_CR8","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1080\/13854046.2013.809795","volume":"27","author":"M Calamia","year":"2013","unstructured":"Calamia M, Markon K, Tranel D. The robust reliability of neuropsychological measures: meta-analyses of test\u2013retest correlations. Clin Neuropsychol. 2013;27(7):1077\u2013105. https:\/\/doi.org\/10.1080\/13854046.2013.809795.","journal-title":"Clin Neuropsychol."},{"issue":"3","key":"894_CR9","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR. \u201cMini-mental state.\u201d A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189\u201398. https:\/\/doi.org\/10.1016\/0022-3956(75)90026-6.","journal-title":"J Psychiatr Res."},{"issue":"4","key":"894_CR10","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.jpsychires.2008.04.014","volume":"43","author":"AJ Mitchell","year":"2009","unstructured":"Mitchell AJ. A meta-analysis of the accuracy of the mini-mental state examination in the detection of dementia and mild cognitive impairment. J Psychiatr Res. 2009;43(4):411\u201331. https:\/\/doi.org\/10.1016\/j.jpsychires.2008.04.014.","journal-title":"J Psychiatr Res"},{"key":"894_CR11","doi-asserted-by":"crossref","unstructured":"Arevalo-Rodriguez I, Smailagic N, i Figuls MR, Ciapponi A, Sanchez-Perez E, Giannakou A, et al. Mini-Mental State Examination (MMSE) for the detection of Alzheimer\u2019s disease and other dementias in people with mild cognitive impairment (MCI). Cochrane Database Syst Rev. 2015;3:1\u201368.","DOI":"10.1002\/14651858.CD010783.pub2"},{"issue":"2","key":"894_CR12","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1177\/1533317514539378","volume":"30","author":"M Lacy","year":"2015","unstructured":"Lacy M, Kaemmerer T, Czipri S. Standardized mini-mental state examination scores and verbal memory performance at a memory center: implications for cognitive screening. Am J Alzheimers Dis Other Demen\u00ae. 2015;30(2):145\u201352.","journal-title":"Am J Alzheimers Dis Other Demen\u00ae"},{"issue":"4","key":"894_CR13","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1080\/0361073X.2013.808109","volume":"39","author":"RJ Spencer","year":"2013","unstructured":"Spencer RJ, Wendell CR, Giggey PP, Katzel LI, Lefkowitz DM, Siegel EL, et al. Psychometric limitations of the mini-mental state examination among nondemented older adults: an evaluation of neurocognitive and magnetic resonance imaging correlates. Exp Aging Res. 2013;39(4):382\u201397. https:\/\/doi.org\/10.1080\/0361073X.2013.808109.","journal-title":"Exp Aging Res"},{"issue":"1","key":"894_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12877-015-0103-3","volume":"15","author":"PT Trzepacz","year":"2015","unstructured":"Trzepacz PT, Hochstetler H, Wang S, Walker B, Saykin AJ. Relationship between the Montreal Cognitive Assessment and Mini-mental State Examination for assessment of mild cognitive impairment in older adults. BMC Geriatr. 2015;15(1):1\u20139.","journal-title":"BMC Geriatr"},{"issue":"26","key":"894_CR15","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1056\/NEJMp1110652","volume":"365","author":"JC Newman","year":"2011","unstructured":"Newman JC, Feldman R. Copyright and open access at the bedside. N Engl J Med. 2011;365(26):2447\u20139. https:\/\/doi.org\/10.1056\/NEJMp1110652.","journal-title":"N Engl J Med"},{"key":"894_CR16","doi-asserted-by":"crossref","unstructured":"de Silva V, Hanwella R. Why are we copyrighting science? BMJ. 2010;341:c4738.","DOI":"10.1136\/bmj.c4738"},{"issue":"1","key":"894_CR17","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1097\/WAD.0000000000000223","volume":"32","author":"S Weintraub","year":"2018","unstructured":"Weintraub S, Besser L, Dodge HH, Teylan M, Ferris S, Goldstein FC, et al. Version 3 of the Alzheimer Disease Centers\u2019 neuropsychological test battery in the Uniform Data Set (UDS). Alzheimer Dis Assoc Disord. 2018;32(1):10\u20137. https:\/\/doi.org\/10.1097\/WAD.0000000000000223.","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"4","key":"894_CR18","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1097\/WAD.0000000000000279","volume":"32","author":"L Besser","year":"2018","unstructured":"Besser L, Kukull W, Knopman DS, Chui H, Galasko D, Weintraub S, et al. Version 3 of the National Alzheimer\u2019s Coordinating Center\u2019s Uniform Data Set. Alzheimer Dis Assoc Disord. 2018;32(4):351\u20138. https:\/\/doi.org\/10.1097\/WAD.0000000000000279.","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"4","key":"894_CR19","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","volume":"53","author":"ZS Nasreddine","year":"2005","unstructured":"Nasreddine ZS, Phillips NA, B\u00e9dirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695\u20139. https:\/\/doi.org\/10.1111\/j.1532-5415.2005.53221.x.","journal-title":"J Am Geriatr Soc"},{"issue":"4","key":"894_CR20","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1017\/S1041610218001370","volume":"31","author":"TC Pinto","year":"2019","unstructured":"Pinto TC, Machado L, Bulgacov TM, Rodrigues-J\u00fanior AL, Costa ML, Ximenes RC, et al. Is the Montreal Cognitive Assessment (MoCA) screening superior to the Mini-Mental State Examination (MMSE) in the detection of mild cognitive impairment (MCI) and Alzheimer\u2019s Disease (AD) in the elderly? Int Psychogeriatr. 2019;31(4):491\u2013504. https:\/\/doi.org\/10.1017\/S1041610218001370.","journal-title":"Int Psychogeriatr"},{"issue":"9","key":"894_CR21","doi-asserted-by":"publisher","first-page":"852","DOI":"10.2174\/1567205016666190805155230","volume":"16","author":"A Eguchi","year":"2019","unstructured":"Eguchi A, Kimura N, Aso Y, Yabuuchi K, Ishibashi M, Hori D, et al. Relationship between the Japanese version of the Montreal Cognitive Assessment and PET imaging in subjects with mild cognitive impairment. Curr Alzheimer Res. 2019;16(9):852\u201360. https:\/\/doi.org\/10.2174\/1567205016666190805155230.","journal-title":"Curr Alzheimer Res"},{"key":"894_CR22","first-page":"1588","volume":"41","author":"JC Morris","year":"1993","unstructured":"Morris JC. The clinical dementia rating (CDR): current version and scoring rules. Neurology. 1993;41:1588\u201392.","journal-title":"Neurology."},{"issue":"2","key":"894_CR23","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1002\/gps.4756","volume":"33","author":"N Carson","year":"2018","unstructured":"Carson N, Leach L, Murphy KJ. A re-examination of Montreal Cognitive Assessment (MoCA) cutoff scores. Int J Geriatr Psychiatry. 2018;33(2):379\u201388. https:\/\/doi.org\/10.1002\/gps.4756.","journal-title":"Int J Geriatr Psychiatry"},{"issue":"5","key":"894_CR24","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.acn.2008.05.004","volume":"23","author":"R Holtzer","year":"2008","unstructured":"Holtzer R, Goldin Y, Zimmerman M, Katz M, Buschke H, Lipton RB. Robust norms for selected neuropsychological tests in older adults. Arch Clin Neuropsychol. 2008;23(5):531\u201341. https:\/\/doi.org\/10.1016\/j.acn.2008.05.004.","journal-title":"Arch Clin Neuropsychol"},{"issue":"5","key":"894_CR25","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1097\/JGP.0b013e31819431d5","volume":"17","author":"AJ Jak","year":"2009","unstructured":"Jak AJ, Bondi MW, Delano-Wood L, Wierenga C, Corey-Bloom J, Salmon DP, et al. Quantification of five neuropsychological approaches to defining mild cognitive impairment. Am J Geriatr Psychiatry. 2009;17(5):368\u201375. https:\/\/doi.org\/10.1097\/JGP.0b013e31819431d5.","journal-title":"Am J Geriatr Psychiatry"},{"issue":"3","key":"894_CR26","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1001\/archneur.56.3.303","volume":"56","author":"RC Petersen","year":"1999","unstructured":"Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol. 1999;56(3):303\u20138. https:\/\/doi.org\/10.1001\/archneur.56.3.303.","journal-title":"Arch Neurol"},{"issue":"11","key":"894_CR27","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1001\/archneurol.2010.272","volume":"67","author":"M Storandt","year":"2010","unstructured":"Storandt M, Morris JC. Ascertainment bias in the clinical diagnosis of Alzheimer disease. Arch Neurol. 2010;67(11):1364\u20139. https:\/\/doi.org\/10.1001\/archneurol.2010.272.","journal-title":"Arch Neurol"},{"issue":"3","key":"894_CR28","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/j.1365-2796.2004.01380.x","volume":"256","author":"B Winblad","year":"2004","unstructured":"Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund LO, et al. Mild cognitive impairment\u2013beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med. 2004;256(3):240\u20136. https:\/\/doi.org\/10.1111\/j.1365-2796.2004.01380.x.","journal-title":"J Intern Med"},{"issue":"10","key":"894_CR29","first-page":"28","volume":"128","author":"TM Therneau","year":"2015","unstructured":"Therneau TM, Lumley T. Package \u2018survival\u2019. R Top Doc. 2015;128(10):28\u201333.","journal-title":"R Top Doc."},{"issue":"1","key":"894_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2105-12-77","volume":"12","author":"X Robin","year":"2011","unstructured":"Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez JC, et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics. 2011;12(1):1\u20138.","journal-title":"BMC Bioinformatics."},{"key":"894_CR31","doi-asserted-by":"publisher","unstructured":"Swets JA. Signal detection theory and ROC analysis in psychology and diagnostics: collected papers. New York: Psychology Press; 2014. https:\/\/doi.org\/10.4324\/9781315806167.","DOI":"10.4324\/9781315806167"},{"key":"894_CR32","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.nicl.2018.04.022","volume":"19","author":"Y Su","year":"2018","unstructured":"Su Y, Flores S, Hornbeck RC, Speidel B, Vlassenko AG, Gordon BA, et al. Utilizing the Centiloid scale in cross-sectional and longitudinal PiB PET studies. NeuroImage Clin. 2018;19:406\u201316. https:\/\/doi.org\/10.1016\/j.nicl.2018.04.022.","journal-title":"NeuroImage Clin"},{"issue":"1","key":"894_CR33","first-page":"180","volume":"11","author":"Y Su","year":"2019","unstructured":"Su Y, Flores S, Wang G, Hornbeck RC, Speidel B, Joseph-Mathurin N, et al. Comparison of Pittsburgh compound B and florbetapir in cross-sectional and longitudinal studies. Alzheimers Dement Diagn Asses Dis Monit. 2019;11(1):180\u201390.","journal-title":"Alzheimers Dement Diagn Asses Dis Monit"},{"issue":"11","key":"894_CR34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0073377","volume":"8","author":"Y Su","year":"2013","unstructured":"Su Y, D\u2019Angelo GM, Vlassenko AG, Zhou G, Snyder AZ, Marcus DS, et al. Quantitative analysis of PiB-PET with freesurfer ROIs. PLoS One. 2013;8(11):e73377. https:\/\/doi.org\/10.1371\/journal.pone.0073377.","journal-title":"PLoS One."},{"key":"894_CR35","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.neuroimage.2017.07.050","volume":"161","author":"S Mishra","year":"2017","unstructured":"Mishra S, Gordon BA, Su Y, Christensen J, Friedrichsen K, Jackson K, et al. AV-1451 PET imaging of tau pathology in preclinical Alzheimer disease: defining a summary measure. Neuroimage. 2017;161:171\u20138. https:\/\/doi.org\/10.1016\/j.neuroimage.2017.07.050.","journal-title":"Neuroimage."},{"issue":"4","key":"894_CR36","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1037\/0894-4105.22.4.491","volume":"22","author":"D Head","year":"2008","unstructured":"Head D, Rodrigue KM, Kennedy KM, Raz N. Neuroanatomical and cognitive mediators of age-related differences in episodic memory. Neuropsychology. 2008;22(4):491\u2013507. https:\/\/doi.org\/10.1037\/0894-4105.22.4.491.","journal-title":"Neuropsychology."},{"issue":"3","key":"894_CR37","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1093\/cercor\/bhm108","volume":"18","author":"N Raz","year":"2008","unstructured":"Raz N, Lindenberger U, Ghisletta P, Rodrigue KM, Kennedy KM, Acker JD. Neuroanatomical correlates of fluid intelligence in healthy adults and persons with vascular risk factors. Cereb Cortex. 2008;18(3):718\u201326. https:\/\/doi.org\/10.1093\/cercor\/bhm108.","journal-title":"Cereb Cortex"},{"issue":"11","key":"894_CR38","doi-asserted-by":"publisher","first-page":"2885","DOI":"10.1093\/brain\/awl256","volume":"129","author":"V Singh","year":"2006","unstructured":"Singh V, Chertkow H, Lerch JP, Evans AC, Dorr AE, Kabani NJ. Spatial patterns of cortical thinning in mild cognitive impairment and Alzheimer\u2019s disease. Brain. 2006;129(11):2885\u201393. https:\/\/doi.org\/10.1093\/brain\/awl256.","journal-title":"Brain."},{"issue":"20","key":"894_CR39","doi-asserted-by":"publisher","first-page":"11050","DOI":"10.1073\/pnas.200033797","volume":"97","author":"B Fischl","year":"2000","unstructured":"Fischl B, Dale AM. Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc Natl Acad Sci. 2000;97(20):11050\u20135. https:\/\/doi.org\/10.1073\/pnas.200033797.","journal-title":"Proc Natl Acad Sci"},{"issue":"11","key":"894_CR40","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1097\/NEN.0000000000000254","volume":"74","author":"J Hassenstab","year":"2015","unstructured":"Hassenstab J, Monsell SE, Mock C, Roe CM, Cairns NJ, Morris JC, et al. Neuropsychological markers of cognitive decline in persons with Alzheimer disease neuropathology. J Neuropathol Exp Neurol. 2015;74(11):1086\u201392. https:\/\/doi.org\/10.1097\/NEN.0000000000000254.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"9","key":"894_CR41","doi-asserted-by":"publisher","first-page":"e859","DOI":"10.1212\/WNL.0000000000006075","volume":"91","author":"AJ Aschenbrenner","year":"2018","unstructured":"Aschenbrenner AJ, Gordon BA, Benzinger TL, Morris JC, Hassenstab JJ. Influence of tau PET, amyloid PET, and hippocampal volume on cognition in Alzheimer disease. Neurology. 2018;91(9):e859\u201366. https:\/\/doi.org\/10.1212\/WNL.0000000000006075.","journal-title":"Neurology."},{"issue":"338","key":"894_CR42","doi-asserted-by":"publisher","first-page":"338ra66","DOI":"10.1126\/scitranslmed.aaf2362","volume":"8","author":"MR Brier","year":"2016","unstructured":"Brier MR, Gordon B, Friedrichsen K, McCarthy J, Stern A, Christensen J, et al. Tau and A\u03b2 imaging, CSF measures, and cognition in Alzheimer\u2019s disease. Sci Transl Med. 2016;8(338):338ra66.","journal-title":"Sci Transl Med"},{"issue":"4","key":"894_CR43","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.3233\/JAD-180507","volume":"65","author":"C Dang","year":"2018","unstructured":"Dang C, Harrington KD, Lim YY, Ames D, Hassenstab J, Laws SM, et al. Relationship between amyloid-\u03b2 positivity and progression to mild cognitive impairment or dementia over 8 years in cognitively normal older adults. J Alzheimers Dis. 2018;65(4):1313\u201325. https:\/\/doi.org\/10.3233\/JAD-180507.","journal-title":"J Alzheimers Dis"},{"key":"894_CR44","first-page":"108","volume":"6","author":"JE Baker","year":"2017","unstructured":"Baker JE, Lim YY, Pietrzak RH, Hassenstab J, Snyder PJ, Masters CL, et al. Cognitive impairment and decline in cognitively normal older adults with high amyloid-\u03b2: a meta-analysis. Alzheimers Dement Diagn Asses Dis Monit. 2017;6:108\u201321.","journal-title":"Alzheimers Dement Diagn Asses Dis Monit"},{"issue":"4","key":"894_CR45","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s11065-017-9366-0","volume":"27","author":"SD Han","year":"2017","unstructured":"Han SD, Nguyen CP, Stricker NH, Nation DA. Detectable neuropsychological differences in early preclinical Alzheimer\u2019s disease: a meta-analysis. Neuropsychol Rev. 2017;27(4):305\u201325.","journal-title":"Neuropsychol Rev"},{"issue":"21","key":"894_CR46","doi-asserted-by":"publisher","first-page":"e2233","DOI":"10.1212\/WNL.0000000000009485","volume":"94","author":"N Mattsson-Carlgren","year":"2020","unstructured":"Mattsson-Carlgren N, Leuzy A, Janelidze S, Palmqvist S, Stomrud E, Strandberg O, et al. The implications of different approaches to define AT (N) in Alzheimer disease. Neurology. 2020;94(21):e2233\u201344. https:\/\/doi.org\/10.1212\/WNL.0000000000009485.","journal-title":"Neurology."},{"issue":"8","key":"894_CR47","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1001\/jamaneurol.2019.1424","volume":"76","author":"BJ Hanseeuw","year":"2019","unstructured":"Hanseeuw BJ, Betensky RA, Jacobs HI, Schultz AP, Sepulcre J, Becker JA, et al. Association of amyloid and tau with cognition in preclinical Alzheimer disease: a longitudinal study. JAMA Neurol. 2019;76(8):915\u201324. https:\/\/doi.org\/10.1001\/jamaneurol.2019.1424.","journal-title":"JAMA Neurol"},{"key":"894_CR48","doi-asserted-by":"publisher","DOI":"10.1002\/alz.038144","volume":"16","author":"J Hassenstab","year":"2020","unstructured":"Hassenstab J, Aschenbrenner AJ, Balota DA, McDade E, Lim YY, Fagan AM, et al. Remote cognitive assessment approaches in the Dominantly Inherited Alzheimer Network (DIAN) Using digital technology to drive clinical innovation in brain-behavior relationships: a new era in neuropsychology. Alzheimers Dement. 2020;16:e038144.","journal-title":"Alzheimers Dement"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-021-00894-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-021-00894-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-021-00894-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,13]],"date-time":"2021-09-13T16:10:08Z","timestamp":1631549408000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-021-00894-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,13]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["894"],"URL":"https:\/\/doi.org\/10.1186\/s13195-021-00894-5","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,13]]},"assertion":[{"value":"8 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Participants provided written informed consent, and all study procedures were approved by the individual ADRCs and approved by Institutional Review Boards as required for participation in NACC.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Neither Dr. Morris nor his family owns stock or has equity interest (outside of mutual funds or other externally directed accounts) in any pharmaceutical or biotechnology company. The other authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"153"}}